about
Systematic association mapping identifies NELL1 as a novel IBD disease geneCharacterization and screening for mutations of the growth arrest-specific 11 (GAS11) and C16orf3 genes at 16q24.3 in breast cancerIndependent and population-specific association of risk variants at the IRGM locus with Crohn's diseaseA Nonsynonymous SNP in ATG16L1 Predisposes to Ileal Crohn’s Disease and Is Independent of CARD15 and IBD5The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel diseaseGenome-wide association defines more than 30 distinct susceptibility loci for Crohn's diseaseHost-microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseMeta-analysis and imputation refines the association of 15q25 with smoking quantityIsolation of a cDNA representing the Fanconi anemia complementation group E geneDirect interaction of FANCD2 with BRCA2 in DNA damage response pathwaysAccurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.High frequency of large intragenic deletions in the Fanconi anemia group A gene.The Fanconi anemia group E gene, FANCE, maps to chromosome 6pGenome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controlsMolecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South AfricaCommon variants at five new loci associated with early-onset inflammatory bowel diseaseGenome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociGenome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controlsGenetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisIL23R variation determines susceptibility but not disease phenotype in inflammatory bowel diseaseA human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group MGenome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A regionMutation analysis of the Fanconi anemia gene FACCSpectrum of mutations in the Fanconi anaemia group G gene, FANCG/XRCC9The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROMDirect interactions of the five known Fanconi anaemia proteins suggest a common functional pathwayDisruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumorsDirect interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transportInteraction of FANCD2 and NBS1 in the DNA damage responseAssociation of DLG5 R30Q variant with inflammatory bowel diseaseFACC gene mutations and early prenatal diagnosis of Fanconi's anaemiaGenetic variation in DLG5 is associated with inflammatory bowel diseaseCharacterisation of the exon structure of the Fanconi anaemia group C gene by vectorette PCRGenetic variation in myosin IXB is associated with ulcerative colitisMapping of a susceptibility locus for Crohn's disease on chromosome 16Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneNovel mutations and polymorphisms in the Fanconi anemia group C geneGenome-wide association analysis identifies 13 new risk loci for schizophreniaCombined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci
P50
Q21090112-0B08F0F7-D255-435C-B56B-F7F8AC258312Q22004026-BF4132EE-9832-4A0A-A73A-868DF8EFB6E6Q22242868-2B6CAB98-21FB-47CA-A682-9AFDAB822E95Q22250941-F0214791-C2B8-4885-BD86-4C1E7618FA6BQ22250943-1DD89AE5-C248-49AC-956B-09B96B799E6DQ22251069-9407AB52-48C6-4D47-B432-D390B1C21697Q22251082-F15864B7-6DDE-4481-A2D7-122D0E8BA108Q24273244-4385E19E-54E1-48EA-ABF1-6D008B5CAC08Q24290289-E4BAA755-A305-4313-9257-7E7BB3D776B2Q24338293-EAA6C708-D20E-47F3-AC83-247416B843DAQ24517912-E20FC27C-6D40-46E0-BBC4-41B0548953D4Q24534222-E9744898-91CE-4986-92AD-B60473026B8BQ24540029-95F9A640-4C9B-4CBB-B4D3-A0D0E379FFA3Q24550675-A4199A2B-FCA5-494A-A209-777420097706Q24595193-8D1ACBB6-8788-4DBB-A2A9-BCF7A0411B7FQ24600801-F06B1585-3359-4A45-9D9D-6B1DFF600E9EQ24618592-DF799133-7D04-41CD-9C5A-53A3E3936409Q24628710-7AEEB18E-D34E-4CD5-9112-2EA7788A7F65Q24635370-2D7F4AE4-1057-4FEF-9287-EAB1D3A2CC78Q24645890-128404AC-2F01-47E3-8087-4B37A8AEB586Q24654206-EBE21204-264F-4FB6-8DA8-07D7B7D9ADC0Q24657139-C5DD92D9-4637-4C34-8706-40862A06C5A8Q24673254-6382E0F3-4141-4B59-B1BC-8B9CAA2C720EQ28138561-CA605F56-ECD1-478D-9A23-98C5D9758F6BQ28141460-3FE5BC04-143E-4322-89B4-4B75C055E061Q28142741-01EEAEF5-840A-4274-B9B2-34D9D1DFE7F0Q28190640-7BA6D5EE-6B7F-420D-807E-055AB0C9CF5BQ28201328-BA5B90BC-4E13-42C9-B034-31DA916B30EFQ28203906-F8C62C5C-1FBD-4183-A2DE-BA43883DFB94Q28215923-87B3E333-CAE9-46E5-8B3B-7A21050C2674Q28246016-A518BEA2-8E1E-491B-9595-95380ECFE62EQ28249258-80D367F4-312E-477F-AC09-6F88CDBF1E20Q28258422-36DAA32F-0DB0-48F2-A4CE-E8F0483EF6FFQ28269055-F83DF8DE-D5BF-4EB4-9BFD-C33252F3627EQ28272638-78D928D3-0E54-435F-ADF1-3BCEA241BFD4Q28275042-6D7D160D-3E03-4814-B24C-E0561E042B38Q28280022-C551DD5F-E52E-4AFD-A625-8BB3FFA181B2Q28292421-78AEAC66-B577-41B6-980A-0A771AB77F56Q28297287-66C05BC8-F931-45F0-83E7-A503C998A4A9Q28924378-AF50F36D-B5DE-4EF0-B74A-66201D49C8AA
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Christopher G Mathew
@nl
Christopher G Mathew
@sl
Christopher G. Mathew
@en
Christopher G. Mathew
@es
Christopher Mathew
@fr
type
label
Christopher G Mathew
@nl
Christopher G Mathew
@sl
Christopher G. Mathew
@en
Christopher G. Mathew
@es
Christopher Mathew
@fr
altLabel
Christopher Mathew
@en
prefLabel
Christopher G Mathew
@nl
Christopher G Mathew
@sl
Christopher G. Mathew
@en
Christopher G. Mathew
@es
Christopher Mathew
@fr
P1053
G-3434-2015
P106
P1153
7004609303
P21
P31
P3829
P496
0000-0003-4178-1838